PETRI DISH PERSPECTIVES
PETRI DISH PERSPECTIVES
Manead Khin
Episode 63: Enveda Biosciences
23 minutes Posted Jul 9, 2026 at 10:00 am.
Rediscovering Natural Products
Founding Story
Turning Plants into Data
Convincing Silicon Valley that Nature Still Matters
Why Nature Still Beats Synthetic Libraries
From Platform to Patients
Partnerships and Industry Recognition
Lessons from Enveda
What’s Next for Enveda?
0:00
23:47
Download MP3
Show notes
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Enveda Biosciences, one of the most exciting AI-native biotech companies redefining how drugs are discovered. While most pharmaceutical companies build vast synthetic chemical libraries, Enveda is using artificial intelligence, metabolomics, and mass spectrometry to unlock the world's largest and largely untapped chemical library: nature. We'll trace the history of natural product drug discovery, from penicil...